The loss of funding appears poised to impact disease spread, resistance, and death rates, in part through its impact on diagnostic testing.
Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.
The firm has multiple infectious disease tests in its pipeline and is currently in initial conversations with potential investors and partners.
With Positive Multi-Site Trial Data, Elypta Poised for Launch of Kidney Cancer Surveillance Test
Premium
The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.